Cited by 253Hormonal and reproductive studiesProstate Cancer Treatment and ResearchEstrogen and related hormone effects

The DOI matches its Crossref record; 118 of the 119 references it cites were found in a registry or an index.

Development of selective androgen receptor modulators (SARMs)

Open access

Narayanan, Ramesh, Coss, Christopher C., Dalton, James T.·2018·Molecular and Cellular Endocrinology

DOI 10.1016/j.mce.2017.06.013PMC PMC5896569

Open this paper in CoChat — free account

Abstract

The Androgen Receptor (AR), a member of the steroid hormone receptor family, plays important roles in the physiology and pathology of diverse tissues. AR ligands, which include circulating testosterone and locally synthesized dihydrotestosterone, bind to and activate the AR to elicit their effects. Ubiquitous expression of the AR, metabolism and cross reactivity with other receptors limit broad therapeutic utilization of steroidal androgens. However, the discovery of selective androgen receptor modulators (SARMs) and other tissue-selective nuclear hormone receptor modulators that activate their cognate receptors in a tissue-selective manner provides an opportunity to promote the beneficial effects of androgens and other hormones in target tissues with greatly reduced unwanted side-effects. In the last two decades, significant resources have been dedicated to the discovery and biological characterization of SARMs in an effort to harness the untapped potential of the AR. SARMs have been proposed as treatments of choice for various diseases, including muscle-wasting, breast cancer, and osteoporosis. This review provides insight into the evolution of SARMs from proof-of-concept agents to the cusp of therapeutic use in less than two decades, while covering contemporary views of their mechanisms of action and therapeutic benefits.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2017.06.013

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,759
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,451
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,202
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163

Show all 119 references

Research works printed but not linked: 1

Ponnusamy, 2016, Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice, J. Cell Biochem.

Sorted by citations

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic, J., Zengin, A., de Courten, B. V., Ebeling, P. R., & Scott, D. S. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186600 · Cited by 603
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Zeng, S., Huang, W., Zheng, X., Cheng, L., Zhang, Z., Wang, J., & Shen, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112981 · Cited by 264
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Hickey, T. E., Selth, L. A., Chia, K. M., Laven‐Law, G., Milioli, H. H., Roden, D. L., Jindal, S., Hui, M. N., Finlay-Schultz, J., Ebrahimie, E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01168-7 · Cited by 261
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
Vignera, S. L., Cannarella, R., Condorelli, R. A., Torre, F., Aversa, A., & Calogero, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082948 · Cited by 234
Osteosarcopenia: A case of geroscience
Kirk, B., Saedi, A. A., & Duque, G. (2019) · Aging Medicine · doi:10.1002/agm2.12080 · Cited by 178
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
Chen, H., Huang, X., Dong, M., Wen, S., Zhou, L., & Yuan, X. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s410834 · Cited by 185
Aging and sex hormones in males
Decaroli, M. C., & Rochira, V. (2016) · Virulence · doi:10.1080/21505594.2016.1259053 · Cited by 150
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies
Liu, D., Wang, S., Liu, S., Wang, Q., Che, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101270 · Cited by 157
Selective androgen receptor modulators: the future of androgen therapy?
Christiansen, A. R., Lipshultz, L. I., Hotaling, J. M., & Pastuszak, A. W. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.02 · Cited by 144
Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
Chen, J., Lin, P., Tsai, Y.-R., Yang, Y.-C., & Kang, H. (2019) · Cells · doi:10.3390/cells8111318 · Cited by 129
An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia
Yang, Y. J., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052604 · Cited by 119
Annual review of PROTAC degraders as anticancer agents in 2022
Wang, X., Qin, Z.-L., Li, N., Jia, M.-Q., Liu, Q.-G., Bai, Y., Song, J., Yuan, S., & Zhang, S. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116166 · Cited by 107
ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use
Nieschlag, E., & Nieschlag, S. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0071 · Cited by 108
A magic drug target: Androgen receptor
Li, D., Zhou, W., Pang, J., Tang, Q., Zhong, B., Shen, C., Li, X., & Hou, T. (2018) · Medicinal Research Reviews · doi:10.1002/med.21558 · Cited by 87
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Mesinovic, J., Fyfe, J. J., Talevski, J., Wheeler, M. J., Leung, G. K. W., George, E. S., Hunegnaw, M. T., Glavas, C., Jansons, P., Daly, R. M., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0112 · Cited by 98
Role of the androgen receptor in the central nervous system
Mhaouty‐Kodja, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.001 · Cited by 90
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression
Basile, D., Cinausero, M., Iacono, D., Pelizzari, G., Bonotto, M., Vitale, M. G., Gerratana, L., & Puglisi, F. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.09.006 · Cited by 82
Matrigel 3D bioprinting of contractile human skeletal muscle models recapitulating exercise and pharmacological responses
Reyes-Furrer, A. A., Andrade, S. D., Bachmann, D., Jeker, H., Steinmann, M., Accart, N., Dunbar, A., Rausch, M., Bono, E., Rimann, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02691-0 · Cited by 80
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials
da Fonseca, G. W. P., Dworatzek, E., Ebner, N., & von Haehling, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1777275 · Cited by 71
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
Elshan, N. G. R. D., Rettig, M. B., & Jung, M. E. (2018) · Medicinal Research Reviews · doi:10.1002/med.21548 · Cited by 69
Osteosarcopenia: beyond age-related muscle and bone loss
Belchior, G. F., Kirk, B., da Silva, E. A. P., & Duque, G. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00355-6 · Cited by 69
Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions
Thevis, M., Walpurgis, K., & Thomas, A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04639 · Cited by 60
Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: Be aware!
Filho, S. L. A. P., Gomes, P. E. A. D. C., Forte, G. A., Lima, L. L. L., da Silva, G. B., Meneses, G. C., Martins, A. M. C., & Daher, E. D. F. (2019) · Nefrología · doi:10.1016/j.nefro.2019.06.003 · Cited by 53
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 54
Therapeutic Strategies to Target the Androgen Receptor
Xiang, W., & Wang, S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00716 · Cited by 50
Clinical significance of androgen receptor expression in triple negative breast cancer‑an immunohistochemistry study
Liu, Y., Zhang, K., & Tang, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8548 · Cited by 48
Development of Pharmacotherapies for the Treatment of Sarcopenia
Rooks, D., & Roubenoff, R. (2019) · The Journal of Frailty & Aging · doi:10.14283/jfa.2019.11 · Cited by 51
Targeting androgen signaling in ILC2s protects from IL-33–driven lung inflammation, independently of KLRG1
Blanquart, E., Mandonnet, A., Mars, M., Cénac, C., Anesi, N., Mercier, P., Audouard, C., Roga, S., de Almeida, G. S., Bevan, C. L., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.029 · Cited by 48
Analysis of supplements available to UK consumers purporting to contain selective androgen receptor modulators
Leaney, A. E., Beck, P., Biddle, S., Brown, P., Grace, P. B., Hudson, S. C., & Mawson, D. H. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2908 · Cited by 47
Hormonal modulation of ESR1 mutant metastasis
Gu, G., Tian, L. H., Herzog, S. K., Rechoum, Y., Gelsomino, L., Gao, M., Du, L., Kim, J.-A., Dustin, D. J., Lo, H. C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01563-x · Cited by 46
Medicinal Use of Testosterone and Related Steroids Revisited
Tauchen, J., Jurášek, M., Huml, L., & Rimpelová, S. (2021) · Molecules · doi:10.3390/molecules26041032 · Cited by 51
The effect of sarcopenia on outcomes following orthopaedic surgery
Brzeszczyński, F. F., Brzeszczynska, J., Duckworth, A. D., Murray, I. R., Simpson, A. H. R. W., & Hamilton, D. F. (2022) · The Bone & Joint Journal · doi:10.1302/0301-620x.104b3.bjj-2021-1052.r1 · Cited by 45
Human in vivo metabolism study of LGD‐4033
Fragkaki, A. G., Sakellariou, P., Kiousi, P., Kioukia‐Fougia, N., Tsivou, M., Petrou, M., & Angelis, Y. S. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2512 · Cited by 44
Identification of potential endocrine disrupting chemicals using gene expression biomarkers
Corton, J. C., Kleinstreuer, N., & Judson, R. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114683 · Cited by 43
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
Maitland, N. J. (2021) · Cancers · doi:10.3390/cancers13020327 · Cited by 44
Androgen Receptor Regulates CD44 Expression in Bladder Cancer
Sottnik, J. L., Vanderlinden, L. A., Joshi, M. U., Chauca-Diaz, A., Owens, C. R., Hansel, D. E., Sempeck, C., Ghosh, D., & Theodorescu, D. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3095 · Cited by 42
Androgen receptor modulators: a review of recent patents and reports (2012-2018)
Fujii, S., & Kagechika, H. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1618831 · Cited by 43
The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
Setordzi, P., Chang, X., Liu, Z., Wu, Y., & Zuo, D. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173867 · Cited by 41
Adverse effects and potential benefits among selective androgen receptor modulators users: a cross-sectional survey
Efimenko, I., Valancy, D., Dubin, J. M., & Ramasamy, R. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00465-0 · Cited by 41
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 48
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Nyquist, M. D., Ang, L. S., Corella, A. N., Coleman, I. M., Meers, M. P., Christiani, A. J., Pierce, C., Janssens, D. H., Meade, H. E., Bose, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146777 · Cited by 42
Self-citation
Sex hormone regulation of innate lymphoid cells
Blanquart, E., Laffont, S., & Guéry, J. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.11.007 · Cited by 38
Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review
Koller, T., Vrbová, P., Mečiarová, I., Molčan, P., Smitka, M., Selčanová, S. A., & Skladaný, Ľ. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i16.4062 · Cited by 43
Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease
Bhasin, S., Krishnan, V., Storer, T. W., Steiner, M., & Dobs, A. S. (2023) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glad027 · Cited by 36
Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine
Ventura, E., Gadaj, A., Monteith, G., Ripoche, A., Healy, J., Botrè, F., Sterk, S. S., Buckley, T., & Mooney, M. H. (2019) · Journal of Chromatography A · doi:10.1016/j.chroma.2019.04.050 · Cited by 36
The molecular consequences of androgen activity in the human breast
Raths, F., Karimzadeh, M., Ing, N., Martinez, A., Yang, Y., Qu, Y., Lee, T.-Y., Mulligan, B., Devkota, S., Tilley, W. T., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100272 · Cited by 39
Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model
Kupreeva, M., Diané, A., Lehner, R. S., Watts, R., Ghosh, M., Proctor, S. D., & Vine, D. F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00018.2018 · Cited by 34
Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer
Gagliano‐Jucá, T., Pencina, K. M., Ganz, T., Travison, T. G., Kantoff, P. W., Nguyen, P. L., Taplin, M., Kibel, A. S., Li, Z., Huang, G. T.-W., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2018 · Cited by 34
Steroid receptor/coactivator binding inhibitors: An update
Skowron, K. J., Booker, K., Cheng, C., Creed, S. M., David, B. P., Lazzara, P. R., Lian, A., Siddiqui, Z., Speltz, T. E., & Moore, T. W. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110471 · Cited by 37
New and developing pharmacotherapy for osteoporosis in men
Gennari, L., & Bilezikian, J. P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1428559 · Cited by 34
The Role of Androgens and Androgen Receptor in Human Bladder Cancer
Martínez-Rojo, E., Berumen, L. C., García‐Alcocer, G., & Escobar-Cabrera, J. E. (2021) · Biomolecules · doi:10.3390/biom11040594 · Cited by 32
Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021)
Xie, Y., Tian, Y., Zhang, Y., Zhang, Z., Chen, R., Li, M., Tang, J., Bian, J., Li, Z., & Xu, X. J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114119 · Cited by 31
Androgen Signaling in Uterine Diseases: New Insights and New Targets
Lv, M., Yu, J., Huang, Y., Ma, J., Xiang, J., Wang, Y., Li, L., Zhang, Z., & Liao, H. (2022) · Biomolecules · doi:10.3390/biom12111624 · Cited by 31
The androgen receptor
Van-Duyne, G., Blair, I. A., Sprenger, C. C. T., Moiseenkova‐Bell, V. Y., Plymate, S. R., & Penning, T. M. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.01.001 · Cited by 32
Selective Androgen Receptor Modulators (SARMs) Effects on Physical Performance: A Systematic Review of Randomized Control Trials
Wen, J., Syed, B., Leapart, J., Shehabat, M., Ansari, U., Akhtar, M., Razick, D., & Pai, D. (2024) · Clinical Endocrinology · doi:10.1111/cen.15135 · Cited by 34
Understanding the biology and advent of physics of cancer with perspicacity in current treatment therapy
Korgaonkar, N., & Yadav, K. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117060 · Cited by 30
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial
Mohan, D., Rossiter, H. B., Watz, H., Fogarty, C. M., Evans, R. A., Man, W. D., Tabberer, M. M., Beerahee, M., Kumar, S., Millns, H., et al. (2022) · Thorax · doi:10.1136/thorax-2021-218360 · Cited by 33
Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects
Khodamoradi, K., Khosravizadeh, Z., Parmar, M., Kuchakulla, M., Ramasamy, R., & Arora, H. (2020) · F&S Reviews · doi:10.1016/j.xfnr.2020.11.001 · Cited by 29
Androgens and Their Role in Regulating Sex Differences in the Hypothalamic/Pituitary/Adrenal Axis Stress Response and Stress-Related Behaviors
Sheng, J. A., Tan, S. M. L., Hale, T. M., & Handa, R. J. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0021 · Cited by 32
Doping and sports endocrinology: anabolic-androgenic steroids
García-Arnés, J. A., & García‐Casares, N. (2022) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2022.09.003 · Cited by 28
Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
Jiménez‐Panizo, A., Pérez, P., Rojas, A. M., Fuentes‐Prior, P., & Estébanez‐Perpiñá, E. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0132 · Cited by 30
A Selective Androgen Receptor Modulator (OPK-88004) in Prostate Cancer Survivors: A Randomized Trial
Pencina, K. M., Burnett, A. L. “., Storer, T. W., Guo, W., Li, Z., Kibel, A. S., Huang, G. T.-W., Blouin, M., Berry, D. L., Basaria, S. S., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab361 · Cited by 28
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
Leciejewska, N., Jędrejko, K., Renaud, V. M. G., Manríquez-Núñez, J., Muszyńska, B., & Pokrywka, A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03592-3 · Cited by 32
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Nyquist, M. D., Ang, L. S., Corella, A. N., Coleman, I. M., Meers, M. P., Christiani, A. J., Pierce, C., Janssens, D. H., Meade, H. E., Bose, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151719 · Cited by 25
Self-citation
Evaluation and management of body composition changes in cancer patients
Wang, J., Tan, S., Gianotti, L. V., & Wu, G. (2023) · Nutrition · doi:10.1016/j.nut.2023.112132 · Cited by 32
The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats
Komrakova, M., Furtwängler, J., Hoffmann, D. B., Lehmann, W., Schilling, A. F., & Sehmisch, S. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00613-1 · Cited by 26
Testosterone Protects Against Atherosclerosis in Male Mice by Targeting Thymic Epithelial Cells—Brief Report
Wilhelmson, A. S., Rodriguez, M. L., Eriksson, E. S., Johansson, I., Fogelstrand, P., Stubelius, A., Lindgren, S., Fagman, J. B., Hansson, G. K., Carlsten, H., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311252 · Cited by 23
Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights
Bhasin, S., Wang, C., Chandra, M. R. G., Gagliano‐Jucá, T., & Jasuja, R. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf041 · Cited by 27
The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments
Venkatesh, V. S., Grossmann, M., Zajac, J. D., & Davey, R. A. (2022) · Obesity Reviews · doi:10.1111/obr.13429 · Cited by 22
Glutamate in Male and Female Sexual Behavior: Receptors, Transporters, and Steroid Independence
Chiang, V. S., & Park, J. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.589882 · Cited by 21
Anabolic steroid misuse and male infertility: management and strategies to improve patient awareness
Whitaker, D. L., Geyer-Kim, G., & Kim, E. D. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1921574 · Cited by 24
The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells
Ma, L., Vidana Gamage, H. E., Tiwari, S., Han, C., Henn, M. A., Krawczynska, N., Dibaeinia, P., Koelwyn, G. J., Das Gupta, A., Bautista Rivas, R. O., et al. (2022) · Endocrinology · doi:10.1210/endocr/bqac072 · Cited by 21
Sarcopenia and bone health: new acquisitions for a firm liaison
Tarantino, U., Greggi, C., Visconti, V. V., Cariati, I., Bonanni, R., Gasperini, B., Nardone, I., Gasbarra, E., & Iundusi, R. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221138354 · Cited by 26
Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer
Liu, W., Zhao, G., Zhang, C., Yang, C., Zeng, X., Li, J., Zhu, K., Zhao, S., Lu, H., Yin, D., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29515 · Cited by 21
Androgen receptor suppresses inflammatory response of airway epithelial cells in allergic asthma through MAPK1 and MAPK14
Xia, T., Ma, J., Sun, Y., & Sun, Y. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221121320 · Cited by 20
Selective Androgen Receptor Modulators: An Emerging Liver Toxin
Mohideen, H., Hussain, H., Dahiya, D. S., & Wehbe, H. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00207 · Cited by 22
A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys
Morimoto, M., Yamaoka, M., & Hara, T. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.563 · Cited by 21
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Crișan, D., Avram, L., Morariu-Barb, A. M., Grapa, C. M., Hirişcău, E. I., Crăciun, R., Donca, V., & Nemeș, A. (2025) · Nutrients · doi:10.3390/nu17010178 · Cited by 21
History of androgens and androgen action
Handelsman, D. J. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101629 · Cited by 19
Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs
Avgeris, I., Pliatsika, D., Nikolaropoulos, S. S., & Fousteris, M. A. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106089 · Cited by 20
The role of cyclins in the development and progression of prostate cancer
Dulińska-Litewka, J., Felkle, D., Dykas, K., Handziuk, Z., Krzysztofik, M., & Gąsiorkiewicz, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113742 · Cited by 21
Attenuation of frailty in older adults with mesenchymal stem cells
Florea, V., Bagno, L., Rieger, A. C., & Hare, J. M. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111120 · Cited by 21
Cardiac cachexia: the mandate to increase clinician awareness
Lena, A., Ebner, N., Coats, A. J. S., & Anker, M. S. (2019) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000456 · Cited by 21
Inhibition of androgen receptor can decrease fat metabolism by decreasing carnitine palmitoyltransferase I levels in skeletal muscles of trained mice
Kim, J., Park, J., Kim, N.-H., Park, H., & Lim, K. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0406-z · Cited by 19
Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f
Morimoto, M., Amano, Y., Oka, M., Harada, A., Fujita, H., Hikichi, Y., Tozawa, R., Yamaoka, M., & Hara, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189480 · Cited by 20
Analysis of the growing public interest in selective androgen receptor modulators
Efimenko, I., Chertman, W., Masterson, T. A., Dubin, J. M., & Ramasamy, R. (2021) · Andrologia · doi:10.1111/and.14238 · Cited by 18
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer
Tien, A. H., & Sadar, M. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031817 · Cited by 17
Annual banned‐substance review: Analytical approaches in human sports drug testing
Thevis, M., Kuuranne, T., & Geyer, H. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2549 · Cited by 17
Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators
Hall, E., & Vrolijk, M. F. (2023) · Nutrients · doi:10.3390/nu15153330 · Cited by 16
Muscle: an independent contributor to the neuromuscular spinal muscular atrophy disease phenotype
Jha, N. N., Kim, J.-K., Her, Y.-R., & Monani, U. R. (2023) · JCI Insight · doi:10.1172/jci.insight.171878 · Cited by 16
Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics
Yoon, J. H., & Kwon, K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1081 · Cited by 16
Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review
Vasireddi, N., Hahamyan, H. A., Gould, H. P., Gregory, A. J. M., Gausden, E. B., Dodson, C. C., Voos, J. E., & Calcei, J. G. (2025) · The American Journal of Sports Medicine · doi:10.1177/03635465241252435 · Cited by 17
A Comprehensive Review of Essential Aspects of Molecular Pathophysiological Mechanisms with Emerging Interventions for Sarcopenia in Older People
Prajapati, P., Kumar, A., Chaudary, R., Mangrulkar, S. V., Arya, M., & Kushwaha, S. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467216666230308142137 · Cited by 17
Pharmacology of doping agents—mechanisms promoting muscle hypertrophy
Parr, M. K., & Laughlin, A. M. M. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.2.131 · Cited by 14
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
Komrakova, M., Nagel, J., Hoffmann, D. B., Lehmann, W., Schilling, A. F., & Sehmisch, S. (2020) · Calcified Tissue International · doi:10.1007/s00223-020-00751-x · Cited by 15
Pharmaceutical Care in Sports
Bomfim, J. H. G. G. (2020) · Pharmacy · doi:10.3390/pharmacy8040218 · Cited by 14
Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport
Bohlin, K. P., Pohanka, A., Andersson, A., Villén, T., & Ekström, L. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3600 · Cited by 14
Androgens and androgen receptor: Above and beyond
Gibson, D. A., Saunders, P. T. K., & McEwan, I. J. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.02.013 · Cited by 14
A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats
Komrakova, M., Büchler, G., Böker, K. O., Lehmann, W., Schilling, A. F., Roch, P. J., Taudien, S., Hoffmann, D. B., & Sehmisch, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01865-9 · Cited by 13

Authors: Narayanan, R., Coss, C. C., & Dalton, J. T.
Affiliations: University of Tennessee Health Science Center (US)
The Ohio State University (US)
University of Michigan (US)
Corresponding author: Dalton, James T.
ORCID: Narayanan, Ramesh
Coss, Christopher C.
Dalton, James T.
Venue: Molecular and Cellular Endocrinology
Publisher: Elsevier BV
Published: 2018-04
Volume: 465
Pages: 134-142
ISSN: 0303-7207 (ISSN-L)
DOI: 10.1016/j.mce.2017.06.013
PMC: PMC5896569
OpenAlex: W2625829876
Cited by: 251
References: 119
Citations by year: 2026: 17 · 2025: 22 · 2024: 19 · 2023: 38 · 2022: 42 · 2021: 37 · 2020: 27 · 2019: 24 · 2018: 21
FWCI: 3.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Molecular and Cellular Endocrinology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (K12CA133250)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: selective androgen receptor modulators, androgen receptor, testosterone, dihydrotestosterone, muscle atrophy, breast cancer, osteoporosis, mechanism of action, drug development
MeSH terms: Androgens, Animals, Humans, Models, Biological, Organ Specificity, Receptors, Androgen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of selective androgen receptor modulators (SARMs)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks